The ad placement follows successful week-long daily protests by attorneys at Gilead’s headquarters in Foster City, California, where groups protested the company’s drug pricing and policies
AHF will run a full-page, full-color newspaper advertisement in the Chronicle on Sunday, October 30, targeting Bay Area drugmaker Gilead and its CEO, Daniel O’Day
On Sunday October 30th AIDS Health Foundation (AHF), will run a full-page, full-color advocacy ad targeting the Bay Area drugmaker’s pricing and policies, Gilead Sciences, Inc. The ad, which will appear in the San Francisco Chronicle, has a simple headline “Greed,” However, the word “greed” is scratched out with three red letters superimposed over the Gilead logo to form the word.
This press release is multimedia. Check out the full release here: https://www.businesswire.com/news/home/20221028005519/en/
AHF’s ad consists of a long and growing list of Gilead’s greedy actions over the years on its HIV/AIDS and hepatitis C drugs that have added tens of billions of dollars to the company’s bottom line, largely at expense of patients and community providers care and mentor them. Points noted in the ad:
“Gilead is notorious for charging $1,000 for a single pill of the Hep-C drug Sovaldi
Gilead is being sued by thousands of HIV patients for knowingly selling a substandard drug until its patent expired out.
Gilead has replaced the inferior drug with Biktarvy and has now cut its patient assistance program.
Gilead’s price for HIV prevention drug Descovy has doubled in the past two years.
Gilead’s greed knows no bounds, making it the poster child for drug company profiteers.”
The Sunday Chronicle advertisement follows a successful baseline campaign which ends today (10/28). The campaign and protests, media coverage from KPIX, KGO and the 340B reportcomprised a week-long string of twice-daily protests by attorneys at Gilead’s headquarters in Foster City, CA, where groups sharply …
